Northern Trust’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-67,204
| Closed | -$24.9K | – | 4530 |
|
|
2025
Q1 | $24.9K | Hold |
67,204
| – | – | ﹤0.01% | 4316 |
|
|
2024
Q4 | $48K | Hold |
67,204
| – | – | ﹤0.01% | 4260 |
|
|
2024
Q3 | $75.3K | Hold |
67,204
| – | – | ﹤0.01% | 4122 |
|
|
2024
Q2 | $73.3K | Sell |
67,204
-54
| -0.1% | -$61 | ﹤0.01% | 4124 |
|
|
2024
Q1 | $85.4K | Sell |
67,258
-46,068
| -41% | -$60.8K | ﹤0.01% | 4121 |
|
|
2023
Q4 | $158K | Buy |
113,326
+9,145
| +9% | +$12.1K | ﹤0.01% | 3980 |
|
|
2023
Q3 | $146K | Sell |
104,181
-399
| -0.4% | -$601 | ﹤0.01% | 3916 |
|
|
2023
Q2 | $192K | Buy |
104,580
+2,165
| +2% | +$5.01K | ﹤0.01% | 3846 |
|
|
2023
Q1 | $249K | Sell |
102,415
-1,321
| -1% | -$1.96K | ﹤0.01% | 3756 |
|
|
2022
Q4 | $148K | Sell |
103,736
-332
| -0.3% | -$647 | ﹤0.01% | 3978 |
|
|
2022
Q3 | $232K | Sell |
104,068
-7,026
| -6% | -$17K | ﹤0.01% | 3815 |
|
|
2022
Q2 | $230K | Sell |
111,094
-439
| -0.4% | -$1.08K | ﹤0.01% | 3859 |
|
|
2022
Q1 | $323K | Sell |
111,533
-2,990
| -3% | -$9.6K | ﹤0.01% | 3920 |
|
|
2021
Q4 | $367K | Buy |
114,523
+7,462
| +7% | +$25.5K | ﹤0.01% | 3925 |
|
|
2021
Q3 | $379K | Sell |
107,061
-3,381
| -3% | -$11.3K | ﹤0.01% | 3872 |
|
|
2021
Q2 | $350K | Sell |
110,442
-346,488
| -76% | -$1.09M | ﹤0.01% | 3864 |
|
|
2021
Q1 | $1.57M | Sell |
456,930
-54,975
| -11% | -$171K | ﹤0.01% | 3374 |
|
|
2020
Q4 | $1.29M | Sell |
511,905
-28,572
| -5% | -$62.2K | ﹤0.01% | 3407 |
|
|
2020
Q3 | $1.14M | Sell |
540,477
-8,388
| -2% | -$19.9K | ﹤0.01% | 3341 |
|
|
2020
Q2 | $1.23M | Buy |
548,865
+7,955
| +1% | +$20.5K | ﹤0.01% | 3282 |
|
|
2020
Q1 | $1.37M | Buy |
540,910
+27,541
| +5% | +$67.7K | ﹤0.01% | 3060 |
|
|
2019
Q4 | $1.35M | Sell |
513,369
-22,259
| -4% | -$66.5K | ﹤0.01% | 3296 |
|
|
2019
Q3 | $1.93M | Sell |
535,628
-26,478
| -5% | -$93.7K | ﹤0.01% | 3123 |
|
|
2019
Q2 | $1.9M | Buy |
562,106
+7,158
| +1% | +$25.2K | ﹤0.01% | 3103 |
|
|
2019
Q1 | $1.51M | Buy |
554,948
+2,089
| +0.4% | +$6.84K | ﹤0.01% | 3220 |
|
|
2018
Q4 | $1.54M | Sell |
552,859
-19,503
| -3% | -$63.9K | ﹤0.01% | 3189 |
|
|
2018
Q3 | $2.36M | Buy |
572,362
+26,373
| +5% | +$120K | ﹤0.01% | 3124 |
|
|
2018
Q2 | $2.83M | Buy |
545,989
+36,237
| +7% | +$221K | ﹤0.01% | 3015 |
|
|
2018
Q1 | $2.79M | Buy |
509,752
+26,563
| +5% | +$187K | ﹤0.01% | 2924 |
|
|
2017
Q4 | $3.94M | Sell |
483,189
-20,445
| -4% | -$195K | ﹤0.01% | 2751 |
|
|
2017
Q3 | $5.27M | Sell |
503,634
-3,245
| -0.6% | -$36K | ﹤0.01% | 2599 |
|
|
2017
Q2 | $5.6M | Buy |
506,879
+40,939
| +9% | +$381K | ﹤0.01% | 2555 |
|
|
2017
Q1 | $3.9M | Buy |
465,940
+8,140
| +2% | +$57.3K | ﹤0.01% | 2708 |
|
|
2016
Q4 | $3.18M | Sell |
457,800
-7,523
| -2% | -$48K | ﹤0.01% | 2837 |
|
|
2016
Q3 | $2.37M | Buy |
465,323
+639
| +0.1% | +$3.82K | ﹤0.01% | 2990 |
|
|
2016
Q2 | $2.77M | Buy |
464,684
+371,935
| +401% | +$2.06M | ﹤0.01% | 2853 |
|
|
2016
Q1 | $422K | Sell |
92,749
-5,042
| -5% | -$22.4K | ﹤0.01% | 3504 |
|
|
2015
Q4 | $440K | Buy |
97,791
+4,078
| +4% | +$17.2K | ﹤0.01% | 3547 |
|
|
2015
Q3 | $297K | Sell |
93,713
-278,087
| -75% | -$844K | ﹤0.01% | 3630 |
|
|
2015
Q2 | $1.13M | Sell |
371,800
-38,291
| -9% | -$108K | ﹤0.01% | 3300 |
|
|
2015
Q1 | $1.21M | Sell |
410,091
-8,581
| -2% | -$28.1K | ﹤0.01% | 3340 |
|
|
2014
Q4 | $1.86M | Buy |
418,672
+16,276
| +4% | +$77.6K | ﹤0.01% | 3150 |
|
|
2014
Q3 | $2.07M | Buy |
402,396
+266,048
| +195% | +$1.42M | ﹤0.01% | 3081 |
|
|
2014
Q2 | $716K | Buy |
136,348
+32,088
| +31% | +$139K | ﹤0.01% | 3509 |
|
|
2014
Q1 | $433K | Buy |
104,260
+7,932
| +8% | +$27.2K | ﹤0.01% | 3574 |
|
|
2013
Q4 | $281K | Sell |
96,328
-3,081
| -3% | -$7.64K | ﹤0.01% | 3633 |
|
|
2013
Q3 | $251K | Sell |
99,409
-13,217
| -12% | -$31.3K | ﹤0.01% | 3600 |
|
|
2013
Q2 | $234K | Buy |
+112,626
| New | +$249K | ﹤0.01% | 3629 |
|
Other funds holding ENZ
RC
XT
KCM
GSC
Northern Trust's ENZ Position: Q2 2025 in Review
Northern Trust sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 67,204 shares — an estimated $24.9K sold.
Northern Trust first reported a position in ENZ in Q2 2013 and held it in 48 quarters. The position peaked at $5.6M in Q2 2017. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.
- Northern Trust reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
- Northern Trust sold 67,204 Enzo Biochem, Inc. shares in Q2 2025, an estimated $24.9K.
- Northern Trust first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 48 quarters.
- Northern Trust's Enzo Biochem, Inc. position peaked at $5.6M in Q2 2017.
- 6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.
Based on Northern Trust's 13F filing for Q2 2025, filed 13 Aug 2025.